Credit Hours: CME 1.00

Target Audience:

Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.

Educational Objectives:

Upon completion of this activity, participants should be able to:

Describe learnings from the mpox epidemic that may improve responses to future infectious diseases outbreaks
Explain the population risk and transmission patterns of circulating respiratory viruses
Identify mechanisms of antimicrobial resistance in epidemiologically significant bacterial and fungal pathogens

Suggested Additional Reading & Joint Accreditation Statement: Note: This Accreditation Statement Supersedes All Other Statements:

Suggested additional reading:

Mitja O, Ogoina D, Titanji BK, et a. Monkeypox. Lancet 2023;401:60-74. PMID: 36403582. doi: https://doi.org/10.1016/s0140-6736(22)02075-x
Giraud-Gatineau A, Kaba L, Boschi C, et a. Control of common viral epidemics but not of SARS-CoV-2 through the application of hygiene and distancing measures. J Clin Virol 2022;150-151:105163. PMID: 35472752. doi: https://doi.org/10.1016/j.jcv.2022.105163
Babiker A, Clark LG, Saul M, Gealey JA, Clancy CJ, Nguyen MH, Shields RK. Changing Epidemiology and Decreased Mortality Associated With Carbapenem-resistant Gram-negative Bacteria, 2000-2017. Clin Infect Dis 2021;73:e4521-e4530. PMID: 32990319. doi: https://doi.org/10.1093/cid/ciaa1464
Castanheira M, et al. Open Forum Infect Dis 2019;6:S23–33.
Antimicrobial Resistance Collaborators Lancet ID 2022;S0140-6736(21)02724-0

Joint Accreditation Statement

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit[s]™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This educational activity is approved for 1.0 contact hours.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Authors:

Graham Snyder, MD, MS — Associate Professor of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine
No relationships with industry relevant to the content of this educational activity have been disclosed.

Ken Ho, MD, MPH — Assistant Professor of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine
No relationships with industry relevant to the content of this educational activity have been disclosed.

Ryan Shields, PharmD, MS — Associate Professor of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine
Dr. Shields receives grant/research support from Merck, Melinta, Roche, Shionogi, and Venatorx. He is a consultant for Cidara, Entasis, GlaxoSmithKline, Menarini, Melinta, Merck, Pfizer, Roche, Shionogi, and Venatorx.

No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This activity is approved for AMA PRA Category 1 Credit™

The University of Pittsburgh is an affirmative action, equal opportunity institution.